title: Can Health Canada protect Canadians from unsafe drugs?
authors.forename: Paul C
authors.initials: PC
authors.lastname: Hébert
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Stanbrook
authors.forename: Noni
authors.initials: N
authors.lastname: MacDonald
authors.forename: Ken
authors.initials: K
authors.lastname: Flegel
authors.forename: Jane
authors.initials: J
authors.lastname: Coutts
authors.forename: Stuart
authors.initials: S
authors.lastname: MacLeod
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D035843:Biomedical Research; D002170:Canada; D004341:Drug Evaluation / Q000331:legislation & jurisprudence / Q000592:standards; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D008004:Licensure / Q000331:legislation & jurisprudence / Q000592:standards; D011358:Product Surveillance, Postmarketing / Q000592:standards